Top-Rated Ligand Pharmaceuticals Nearing A Buy Point

Ligand Pharmaceuticals, which has a highest-possible IBD Composite Rating of 99, is getting close to a buy point. Industry group peers Amgen and Alexion Pharmaceuticals have also formed bases. Should these biotechs be added to your stock watch list?

Advertisement